An alternative treatment for pityriasis versicolor, tinea cruris, tinea corporis and tinea faciei with topical application of honey, olive oil and beeswax mixture: an open pilot study

2004 ◽  
Vol 12 (1) ◽  
pp. 45-47 ◽  
Author(s):  
N.S Al-Waili
Keyword(s):  
Pilot Study ◽  
Olive Oil ◽  
Topical Application ◽  
Alternative Treatment ◽  
Pityriasis Versicolor ◽  
Tinea Corporis ◽  
Tinea Cruris ◽  
Tinea Faciei ◽  
Open Pilot

Guidelines of care for superficial mycotic infectionsof the skin: Tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis

1996 ◽  
Vol 34 (2) ◽  
pp. 282-286 ◽  
Author(s):  
Lynn A. Drake ◽  
Scott M. Dinehart ◽  
Evan R. Farmer ◽  
Robert W. Goltz ◽  
Gloria F. Graham ◽  
...  
Keyword(s):  
Tinea Pedis ◽  
Tinea Corporis ◽  
Tinea Cruris ◽  
Tinea Faciei

scholarly journals Futility of combining griseofulvin and terbinafine in current epidemic of altered dermatophytosis in India: Results of a randomized pragmatic trial

2019 ◽  
Author(s):  
Sanjay Singh ◽  
Vinayak N Anchan ◽  
Radhika Raheja
Keyword(s):  
Pragmatic Trial ◽  
Tinea Corporis ◽  
Number Needed To Treat ◽  
Recent Past ◽  
Cure Rate ◽  
Once Daily ◽  
Tinea Cruris ◽  
Tinea Faciei ◽  
Treatment Responsiveness ◽  
Oral Terbinafine

AbstractBackgroundTreatment responsiveness of tinea has decreased considerably in recent past in India. We tested effectiveness of oral terbinafine plus griseofulvin versus terbinafine alone in tinea corporis, tinea cruris and tinea faciei in a randomized pragmatic open trial.MethodsOne hundred and thirty two microscopy confirmed patients were randomly allocated (ratio 1:1) to two groups, terbinafine (T) and terbinafine plus griseofulvin (T+G). Doses given were as follows: T, oral terbinafine (6 mg/kg/day, maximum 500 mg/day, once daily); T+G, terbinafine (as above) plus oral griseofulvin (children [<18 years] 10 mg/kg/day, adults [18 years or more] 10 mg/kg/day, but not <500 mg and not >1000 mg per day, in two divided doses). Patients were treated for 8 weeks or cure, whichever occurred earlier.ResultsAt 4 weeks, none of the patients were cured in both groups. At 6 weeks, 1(1.5%) and 4 (6.1%) patients were cured in T and T+G groups, respectively (P=0.417). At 8 weeks, 17 (25.8%) and 19 (28.8%) patients were cured in T and T+G groups, respectively (P=0.845). For cure rate at 8 weeks, number needed to treat (NNT) for T+G (versus T), was 33.ConclusionsAddition of griseofulvin to terbinafine does not increase effectiveness of terbinafine in current epidemic of altered dermatophytosis in India.

Tolciclate versus Miconazole, a Double-Blind Trial in Patients with Dermatomycosis

1980 ◽  
Vol 8 (2) ◽  
pp. 144-147 ◽  
Author(s):  
L C Cucè ◽  
B F Contijo Assunção ◽  
L G A Medawar ◽  
A Salibian ◽  
W Groppi
Keyword(s):  
Tinea Pedis ◽  
Pityriasis Versicolor ◽  
Tinea Corporis ◽  
Double Blind Trial ◽  
Double Blind ◽  
Tinea Cruris ◽  
Blind Trial

Eighty-one patients with dermatomycosis such as tinea corporis, tinea cruris, tinea pedis and pityriasis versicolor were treated with tolciclate 1% cream or miconazole 2% cream. Parasitological cure was obtained in 100% of the patients given tolciclate and in 97.4% of those given miconazole. Patients and investigator considered tolciclate treatment as excellent, respectively, in 76.2% and 73.8% of the cases. The corresponding figures for miconazole were 74.4% and 66.7%. Both treatments were well tolerated.

Sign in / Sign up

Export Citation Format

Share Document